Brunswick Receives Patent Pending Notice
February 2, 2004
1 Min Read
Brunswick Receives Patent Pending Notice
WAREHAM, Mass.BrunswickLaboratories received notification of patent pending status for itslipophilic ORAC (oxygen radical absorbance capacity) assay. According to thecompany, the test complements existing hydrophilic ORAC assays, permittingoil-soluble substances to be accurately tested for antioxidant activity.
Getting to this phase in the patent process is gratifying,said Jim Nichols, chief executive officer of Brunswick (www.brunswicklabs.com).It demonstrates our commitment to innovation and excellencein the field of antioxidants, and helps assure our customers of the quality andvalue they can expect from our analytical services.
Subscribe for the latest consumer trends, trade news, nutrition science and regulatory updates in the supplement industry!
Join 37,000+ members. Yes, it's completely free.
You May Also Like